Open AccessImpact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trial
Author(s) -
Margarida Tavares,
Mariana Farraia,
Susana Silva,
Ana Margarida Ribeiro,
Milton Severo,
Inês Paciência,
Raquel Ribeiro,
Venceslau Hespanhol,
Tiago Guimarães,
Jorge Almeida,
Fernando Magro,
António Sarmento,
Ana Marta Oliveira,
André Moreira
Publication year - 2021
Publication title -
porto biomedical journal/porto biomedical journal
Language(s) - English
Resource type - Journals
eISSN - 2444-8672
pISSN - 2444-8664
DOI - 10.1097/j.pbj.0000000000000134
Subject(s) - montelukast , medicine , randomized controlled trial , pneumonia , clinical trial , adverse effect , covid-19 , clinical endpoint , intensive care medicine , drug , surrogate endpoint , pharmacology , disease , asthma , infectious disease (medical specialty)